Metagenomi Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.19

-0.01 (-0.83%)

As of Jun 30, 10:39 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +2,471.4% upside

Low Target $21.05

Average Target $30.60

High Target $40.98

Current Price $1.19

Current
$1.19

Target
$30.60

$21.05 $30.60 avg $40.98

Scenario Analysis

Bear Case

$21.05

1,668.9%

Low target

Base Case

$30.60

+2,471.4%

Avg target

Bull Case

$40.98

+3,343.7%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$3.95

-69.9% from high

52-Week Low

$1.13

+5.3% from low

Target vs 52W High

$30.60

+674.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%